Temaz and Durezol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Temaz (temazepam) and Durezol (difluprednate). Common drug interactions include vitreous haemorrhage among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Temaz and Durezol. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Temaz?

Temaz has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 42,293 Temaz users. Check the latest studies of Temaz.

What is Durezol?

Durezol has active ingredients of difluprednate. It is often used in uveitis. eHealthMe is studying from 3,441 Durezol users. Check the latest studies of Durezol.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 30, 2026

21 people who take Temaz and Durezol together, and have interactions are studied.

Temaz and Durezol drug interactions.

What are the common drug interactions of Temaz and Durezol, by gender? *:

female:

  1. Vitreous haemorrhage (intraocular (inside the eye) bleeding)
  2. Arthritis enteropathic (form of chronic, inflammatory arthritis associated with the occurrence of an inflammatory bowel disease)
  3. Blindness
  4. Chronic kidney disease
  5. Bone pain
  6. Constipation
  7. Contusion (a type of hematoma of tissue in which capillaries)
  8. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  9. Drug ineffective
  10. Eye pain

male:

  1. Chronic kidney disease
  2. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  3. Deafness unilateral
  4. Dental discomfort
  5. Diarrhoea haemorrhagic (bloody diarrhoea)
  6. Dizziness
  7. Dry mouth
  8. Dyspnoea (difficult or laboured respiration)
  9. Epistaxis (bleed from the nose)
  10. Eye disorder

What are the common drug interactions of Temaz and Durezol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Arthritis enteropathic (form of chronic, inflammatory arthritis associated with the occurrence of an inflammatory bowel disease)

20-29:

  1. Diarrhoea haemorrhagic (bloody diarrhoea)

30-39:

n/a

40-49:

  1. Bone pain
  2. Chronic kidney disease
  3. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  4. Migraine (headache)
  5. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  6. Nephrogenic anaemia (anaemia due to kidney disease)
  7. Pain
  8. Renal failure (kidney dysfunction)
  9. Tearfulness (excess tearing)

50-59:

  1. Chronic kidney disease

60+:

  1. Chronic kidney disease
  2. Vitreous haemorrhage (intraocular (inside the eye) bleeding)
  3. Contusion (a type of hematoma of tissue in which capillaries)
  4. Deafness unilateral
  5. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  6. Dental discomfort
  7. Dizziness
  8. Drug ineffective
  9. Dry mouth
  10. Dyspnoea (difficult or laboured respiration)

What are the existing conditions these people have? *

  1. High Blood Pressure: 5 people, 23.81%
  2. High Blood Cholesterol: 5 people, 23.81%
  3. Pain: 4 people, 19.05%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 19.05%
  5. Inflammation: 4 people, 19.05%
  6. Constipation: 4 people, 19.05%
  7. Neuralgia (pain in one or more nerves): 3 people, 14.29%
  8. Nausea (feeling of having an urge to vomit): 3 people, 14.29%
  9. Muscle Spasms (muscle contraction): 3 people, 14.29%
  10. Muscle Aches (muscle pain): 3 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Temaz and Durezol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Temaz and Durezol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Temaz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Durezol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Temaz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Durezol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on temazepam and difluprednate (the active ingredients of Temaz and Durezol, respectively), and Temaz and Durezol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: